Locking Down Blood Pressure Protects Brain Health

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

MONDAY, Jan. 27, 2025 -- Maintaining tight control over blood pressure for even a short while can provide lasting benefits for seniors’ brain health, a new clinical trial says.

People had lower risk of mild cognitive impairment or dementia after keeping their blood pressure around 120 systolic for three and a half years, according to results published recently in the journal Neurology. (Systolic pressure, the top number in a blood pressure reading, measures the pressure in arteries when the heart pumps blood.)

What’s more, this reduced risk stayed with seniors long after they stopped such intense blood pressure treatment.

“Our study shows that intensive blood pressure control is an important strategy in the prevention of cognitive impairment, a major cause of loss of independence in older adults,” said senior researcher Dr. Jeff Williamson, a professor of gerontology and geriatric medicine at Wake Forest University School of Medicine in Winston-Salem, N.C.

“Lowering your blood pressure to more aggressive targets can improve the quality of life and extend active life for individuals with hypertension,” Williamson added in a news release.

The new study is the latest from a landmark clinical trial which, in 2015, reported that intensive blood pressure management reduced risk of heart disease and death by 30% to 40% in people with high blood pressure.

The trial -- called the Systolic Blood Pressure Intervention Trial, or SPRINT -- compared the health of people whose blood pressure was lowered to 120 systolic against others whose target was 140 systolic.

In 2019, further results from SPRINT showed a significantly reduced risk of mild cognitive impairment for up to five years following a period of intensive blood pressure control.

These latest findings from SPRINT followed patients for even longer, at least seven years, and found that the brain benefits of blood pressure control are indeed long-lasting.

The new paper reports on more than 7,000 participants from the initial trial who could be re-contacted. These folks took part in cognitive testing to check their brain function.

People who had gotten intensive blood pressure treatment during the trial were 13% less likely to have mild cognitive impairment and 11% less likely to have either mild cognitive impairment or dementia, compared with those whose blood pressure target was higher, researchers report.

“Over a median of almost seven years of follow-up, we observed that the previously reported statistically significant reduction in the rate of cognitive impairment …was maintained,” the researchers wrote.

“It is important to remember that participants randomized to intensive treatment underwent an average of just 3.3 years of intervention, after which the same level of intensive treatment of hypertension was generally not maintained,” they added.

“Thus, these data support intensive blood pressure treatment as an important strategy for the prevention of cognitive impairment and suggest some degree of persistent benefit on the development of cognitive impairment from even a few years of intensive treatment,” the researchers concluded.

Current blood pressure guidelines put normal blood pressure at 120 or less, elevated at 120 to 129, and high blood pressure at 130 or more. Leading heart health groups set these guidelines in 2017 based in part on the first results from SPRINT.

Sources

  • Wake Forest University, news release, Jan. 21, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-01-28 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords